These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21506278

  • 1. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
    Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Darji B, Siriki Y, Bandyopadhyay D, Joharapurkar A, Kshirsagar S, Patel H, Shaikh M, Sairam KV, Patel P.
    ChemMedChem; 2011 Jun 06; 6(6):1011-6. PubMed ID: 21506278
    [No Abstract] [Full Text] [Related]

  • 2. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
    Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Joharapurkar A, Dhanesha N, Shaikh M, Sairam KV, Kapadnis P.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1111-7. PubMed ID: 22189136
    [Abstract] [Full Text] [Related]

  • 3. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, He H, Hickey GJ, Kowalchick JE, Leiting B, Lyons K, Marsilio F, McCann ME, Patel RA, Petrov A, Scapin G, Patel SB, Roy RS, Wu JK, Wyvratt MJ, Zhang BB, Zhu L, Thornberry NA, Weber AE.
    J Med Chem; 2005 Jan 13; 48(1):141-51. PubMed ID: 15634008
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G, Paoli P, León-Rivera I, Villalobos-Molina R, Medina-Franco JL, Ortiz-Andrade R, Estrada-Soto S, Camici G, Diaz-Coutiño D, Gallardo-Ortiz I, Martinez-Mayorga K, Moreno-Díaz H.
    Bioorg Med Chem; 2009 May 01; 17(9):3332-41. PubMed ID: 19362487
    [Abstract] [Full Text] [Related]

  • 5. Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
    Ajmani S, Karanam S, Kulkarni SA.
    Chem Biol Drug Des; 2009 Dec 01; 74(6):582-95. PubMed ID: 19824894
    [Abstract] [Full Text] [Related]

  • 6. Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.
    Basu S, Prasad UV, Barawkar DA, De S, Palle VP, Menon S, Patel M, Thorat S, Singh UP, Das Sarma K, Waman Y, Niranjan S, Pathade V, Gaur A, Reddy S, Ansari S.
    Bioorg Med Chem Lett; 2012 Apr 15; 22(8):2843-9. PubMed ID: 22424978
    [Abstract] [Full Text] [Related]

  • 7. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
    Liu G, Szczepankiewicz BG, Pei Z, Janowick DA, Xin Z, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR.
    J Med Chem; 2003 May 22; 46(11):2093-103. PubMed ID: 12747781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N, El-Sayed NM, Abdelhameed R, Yamada K, Elgawish MS.
    Bioorg Chem; 2019 May 22; 86():322-338. PubMed ID: 30743173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
    Fukuda S, Ohta T, Sakata S, Morinaga H, Ito M, Nakagawa Y, Tanaka M, Matsushita M.
    Diabetes Obes Metab; 2010 Apr 22; 12(4):299-306. PubMed ID: 20380650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Aster SD, Graham DW, Kharbanda D, Patel G, Ponpipom M, Santorelli GM, Szymonifka MJ, Mundt SS, Shah K, Springer MS, Thieringer R, Hermanowski-Vosatka A, Wright SD, Xiao J, Zokian H, Balkovec JM.
    Bioorg Med Chem Lett; 2008 May 01; 18(9):2799-804. PubMed ID: 18434143
    [Abstract] [Full Text] [Related]

  • 19. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P, Geronikaki A, Petrou A.
    Curr Top Med Chem; 2019 May 01; 19(4):246-263. PubMed ID: 30714526
    [Abstract] [Full Text] [Related]

  • 20. 7-Phenyl-pyrido[2,3-d]pyrimidine-2,4-diamines: novel and highly selective protein tyrosine phosphatase 1B inhibitors.
    Cheung AW, Banner B, Bose J, Kim K, Li S, Marcopulos N, Orzechowski L, Sergi JA, Thakkar KC, Wang BB, Yun W, Zwingelstein C, Berthel S, Olivier AR.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7518-22. PubMed ID: 23122867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.